Celiac Sprue and/or dermatitis herpetiformis arc treated by interfering with HLA binding of immunogenic gluten peptides. The antigenicity of gluten oligopeptides and the ill effects caused by an immune response thereto are decreased by administration of an HLA-binding peptide inhibitor. Such inhibitors are analogs of immunogenic gluten peptides and (i) retain the ability to bind tightly to HLA molecules; (ii) retain the protcolytic stability of these peptides; but (iii) are unable to activate disease-specific T cells.

 
Web www.patentalert.com

< Antisense oligonucleotide against human acetylcholinesterase (AChE) and uses thereof

< Novel enhanced multiple viscosity liner

> Propenoyl hydrazides

> Methods and compositions for treatment of neurological disorder

~ 00220